Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

BACKGROUND: We assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database. METHODS: We collected data on newly prescribed sitagliptin, vildagliptin, and pioglitazone between January 1, 2009 and D...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Metab J
Päätekijät: Suh, Sunghwan, Seo, Gi Hyeon, Jung, Chang Hee, Kim, Mee-Kyoung, Jin, Sang-Man, Hwang, You-Cheol, Lee, Byung-Wan, Kim, Jae Hyeon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Diabetes Association 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483610/
https://ncbi.nlm.nih.gov/pubmed/26124995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.3.247
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia